Vinci S.A. Stock

Surgical robots aren't new. Intuitive Surgical (NASDAQ: ISRG) has been selling them for years. In fact, the company's installed base of robots rose to just over 11,100 by the end of 2025. The

Shares of leading robotic-assisted surgery (RAS) specialist Intuitive Surgical (NASDAQ: ISRG) are up 8% as of noon ET on Wednesday after the company sailed past Wall Street's expectations with its

Intuitive Surgical (NASDAQ: ISRG) is the dominant manufacturer of robotic surgical systems. The healthcare company's da Vinci Xi, designed for soft-tissue operations, is the most widely used

Intuitive Surgical (NASDAQ: ISRG) has faced significant challenges over the past year, especially related to tariffs. The company's shares have lagged broader equities as a result, and with the

Some of the most successful investors understand that the power of equity markets lies in their ability to generate consistent returns over the long run. While most traders lose money, people who

Intuitive Surgical (NASDAQ: ISRG) reported exceptional fourth-quarter and full-year 2025 results earlier this year. Revenue and procedure volumes grew at robust double-digit rates as the company

Intuitive Surgical (NASDAQ: ISRG) makes the da Vinci surgical robot system. The company's products, including the parts and services that support its robots, have been in high demand for years. Wall

Intuitive Surgical (NASDAQ: ISRG) has a huge 64 price-to-earnings ratio. Medtronic (NYSE: MDT), a competitor in the medical device niche, has a P/E ratio of 26. There's an opportunity here for

Intuitive Surgical (NASDAQ: ISRG) is a promising healthcare company that could help revolutionize the sector. Its da Vinci surgical systems can help make surgery more precise and lead to better

You may have come in close contact with Intuitive Surgical (NASDAQ: ISRG) if you've ever had hernia repair, gallbladder surgery, or other minimally invasive surgeries. The company's flagship Da

Intuitive Surgical (NASDAQ: ISRG) is not going to interest value-conscious investors. In fact, with a price-to-earnings ratio of 60, it is quite an expensive stock. For reference, the S&P 500 index

Baxter International (NYSE: BAX) was a dividend stock, but it's no longer one. That's because the dividend was just cut from $0.17 per share per quarter to a token penny. Dividend lovers will want

Intuitive Surgical (NASDAQ: ISRG) ended 2025 on a strong note. The tech/healthcare company placed 532 of its da Vinci surgical robots in the fourth quarter, up from 493 in the final quarter of 2024

For the most part, artificial intelligence (AI) is just a complex computer program that uses data to inform its decision-making process. Essentially, it needs to be trained. If you are looking for

Attractive stocks to buy and hold for the long term tend to possess several key qualities. They are often highly innovative leaders in industries with huge growth potential. And they inevitably have

Novo Nordisk (NYSE: NVO) and Intuitive Surgical (NASDAQ: ISRG) are both healthcare leaders, but they operate in different corners of this vast sector. The former markets pharmaceutical drugs, while

There are many aspects of Intuitive Surgical's (NASDAQ: ISRG) business to appreciate. However, as famous investor Benjamin Graham one said, a good company can be a bad investment if you pay too much

Over the past 25 years, Intuitive Surgical (NASDAQ: ISRG) has experienced significant success thanks to its pioneering use of robotics in surgery. The healthcare leader now stands as the undisputed

Intuitive Surgical (NASDAQ: ISRG) Intuitive Surgical is the leader in robotic surgery equipment. It has more than 9,900 of its million-dollar-plus da Vinci robotic surgery systems installed in 72

Intuitive Surgical (NASDAQ: ISRG) is a growth stock, and because of that, it is evaluated differently by investors. For instance, investors pay a huge amount of attention to the number of da Vinci

Shares of Intuitive Surgical (NASDAQ: ISRG) have rallied over 30% in a month, vastly outdistancing the S&P 500 index's 4% gain over the same span. Should you sell shares of this surgical robotics

There is a lot to like about Intuitive Surgical (NASDAQ: ISRG) and one very notable thing to dislike. And once you see the problem, you'll instantly understand why medical device competitor

Shares of Intuitive Surgical (NASDAQ: ISRG) rose 19.5% in October, according to data from S&P Global Market Intelligence. The maker of da Vinci robotic surgery systems posted third-quarter results